Clopidogrel and Aspirin versus Aspirin Alone in Stroke Patients "PLUTO"
Completed
Phase N/A ResultsSummary of Purpose
To determine whether clopidogrel with aspirin (C+ASA) will produce more potent platelet inhibition than aspirin alone (ASA) in patients after ischemic stroke.
Read More →Trial Milestones
The following dates are available for this trial. Trial information last updated on 26 September 2005.
| Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Start Date | First Received | 1st Completion | Completion | Verification | Results |
|---|
Trial Basics
Interventions
Sponsors
- Sanofi-Aventis/Bristol-Myers Squibb Partnership New York, NY.
Trial Design
Randomized, controlled, antiplatelet trial.
Contacts
Not available
Recruitment
- Gender: Both
- Study Size: 70
- Number of Centers: 1
- Max Time from Onset: 3 Months
Principal Investigator
-
Victor L. Serebruany, MD, PhD
Victor L. Serebruany, MD, PhD HeartDrug Research Laboratories Osler Medical Center 7600 Osler Dr, Suite 307 Towson, MD, 21204
